Noninvasive proteomic biomarkers for alcohol-related liver diseaseLili Niu, Matthias Mann, Maja Thiele et al.|Nature Medicine|2022Cited by 318
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjærgaard, Aleksander Krag, Katrine Prier Lindvig et al.|Journal of Hepatology|2023Cited by 213
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort studyMads Israelsen, Aleksander Krag, Nikolaj Torp et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 152
Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver diseaseDitlev Nytoft Rasmussen, Maja Thiele, Stine Johansen et al.|Journal of Hepatology|2021Cited by 141
A global research priority agenda to advance public health responses to fatty liver diseaseHenry E. Mark, Alina M. Allen, Juan Pablo Arab et al.|Journal of Hepatology|2023Cited by 132